The purpose of this study is to determine whether patients with asthma are better able to manage and control their symptoms by using one inhaler daily that both prevents as well as treats the symptoms of an asthma exacerbation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
550
In a real life setting, to compare Symbicort® Single Inhaler Therapy with a patient's previous therapy (including low dose ICS), by assessment of the changes in the Asthma Control Questionnaire score in uncontrolled asthmatic patients.
Change in forced expiratory volume in one second (FEV1)
Change in peak expiratory flow (PEF)
Patient Reported Outcomes: AQLQ(S), SATQ, RCP-3 scores
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Fowey, Cornwall, United Kingdom
Research Site
Hove, East Sussex, United Kingdom
Research Site
Ilford, Essex, United Kingdom
Research Site
Glenrothes, Fife, United Kingdom
Research Site
Dartford, Kent, United Kingdom
Research Site
Airdrie, Lanarkshire, United Kingdom
Research Site
Hamilton, Lanarkshire, United Kingdom
Research Site
Doncaster, North Yorkshire, United Kingdom
Research Site
Cookstown, Northern Ireland, United Kingdom
Research Site
Downpatrick, Northern Ireland, United Kingdom
...and 49 more locations